NASDAQ:ALLO
Allogene Therapeutics Stock News
$2.59
-0.180 (-6.50%)
At Close: May 20, 2024
What's in Store for Innoviva (INVA) This Earnings Season?
03:58pm, Tuesday, 28'th Apr 2020
Strong demand for Glaxo's Trelegy Ellipta is likely to have driven royalties for Innoviva (INVA) in the first quarter.
NI sisters raise £20k for blood cancer charity in just 12 hours
08:14pm, Monday, 27'th Apr 2020
The girls wanted to do something special to mark the end of Anita's chemotherapy treatment
Allogene Therapeutics to Report First Quarter 2020 Financial Results on May 6, 2020
12:30pm, Monday, 27'th Apr 2020
The announcement will be followed by a live audio webcast and conference call at 5:30 AM Pacific Time/8:30 AM Eastern Time. Following the live audio webcast, a replay will be available on the Company
Allogene Therapeutics to Report First Quarter 2020 Financial Results on May 6, 2020
12:30pm, Monday, 27'th Apr 2020
Conference Call and Webcast Scheduled for 5:30 AM PT/8:30 AM ET SOUTH SAN FRANCISCO, Calif., April 27, 2020 (GLOBE NEWSWIRE) -- Allogene Therapeutics,...
Bank of America Corp DE Has $740,000 Holdings in Allogene Therapeutics Inc (NASDAQ:ALLO)
08:44am, Sunday, 26'th Apr 2020
Bank of America Corp DE lessened its position in Allogene Therapeutics Inc (NASDAQ:ALLO) by 24.0% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 28,502 sha
Allogene's Shares March Higher, Can It Continue?
11:15am, Wednesday, 22'nd Apr 2020
As of late, it has definitely been a great time to be an investor in Allogene Therapeutics.
Allogene's Shares March Higher, Can It Continue?
11:15am, Wednesday, 22'nd Apr 2020
As of late, it has definitely been a great time to be an investor in Allogene Therapeutics.
Allogene Therapeutics (NASDAQ:ALLO) Rating Increased to Buy at BidaskClub
09:12am, Tuesday, 21'st Apr 2020
BidaskClub upgraded shares of Allogene Therapeutics (NASDAQ:ALLO) from a hold rating to a buy rating in a report issued on Friday morning, BidAskClub reports. Other equities research analysts have als
Is Allogene Therapeutics (ALLO) Stock Outpacing Its Medical Peers This Year?
03:30pm, Friday, 17'th Apr 2020
Is (ALLO) Outperforming Other Medical Stocks This Year?
Is Allogene Therapeutics (ALLO) Stock Outpacing Its Medical Peers This Year?
03:30pm, Friday, 17'th Apr 2020
Is (ALLO) Outperforming Other Medical Stocks This Year?
Bank of New York Mellon Corp Purchases 8,801 Shares of Allogene Therapeutics Inc (NASDAQ:ALLO)
09:52am, Friday, 17'th Apr 2020
Bank of New York Mellon Corp lifted its stake in shares of Allogene Therapeutics Inc (NASDAQ:ALLO) by 6.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchan
Allogene Therapeutics Inc (NASDAQ:ALLO) Forecasted to Earn Q1 2020 Earnings of ($0.56) Per Share
06:54am, Friday, 17'th Apr 2020
Allogene Therapeutics Inc (NASDAQ:ALLO) – Equities researchers at SunTrust Banks issued their Q1 2020 earnings estimates for Allogene Therapeutics in a research report issued to clients and investor
Here's Why Momentum Investors Will Love Allogene Therapeutics (ALLO)
04:00pm, Thursday, 16'th Apr 2020
Does Allogene Therapeutics (ALLO) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here's Why Momentum Investors Will Love Allogene Therapeutics (ALLO)
04:00pm, Thursday, 16'th Apr 2020
Does Allogene Therapeutics (ALLO) have what it takes to be a top stock pick for momentum investors? Let's find out.
Allogene Therapeutics (ALLO) Received its Third Buy in a Row
04:23am, Wednesday, 15'th Apr 2020
After William Blair and Canaccord Genuity gave Allogene Therapeutics (NASDAQ: ALLO) a Buy rating last month, the company received another Buy, this time
